
Rocket Pharmaceuticals Inc (RCKTW)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -35.275 | -25.492 | -42.209 | -24.789 | -29.015 | -31.083 | -42.307 | -43.929 |
Return on Equity (%) | -47.097 | -48.783 | -61.636 | -30.826 | -34.459 | -35.287 | -46.984 | -50.006 |
Return on Invested Capital (%) | -36.317 | -24.008 | -44.027 | -26.42 | -31.401 | -36.021 | -53.373 | -61.222 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 2.711 | 6.764 | 3.616 | 5.044 | 7.75 | 6.572 | 5.369 | 4.75 |
Earnings Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
Cash Per Share | 1.104 | 11.147 | 2.467 | 3.385 | 4.871 | 3.607 | 1.776 | 0.62 |
Working Capital Per Share | 4.489 | 13.732 | 4.291 | 5.285 | 7.455 | 5.734 | 4.106 | 3.657 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
EBITDA Per Share | -1.588 | -4.177 | -1.651 | -1.411 | -2.29 | -2.621 | -2.804 | -2.724 |
Free Cash Flow Per Share | -1.576 | -4.195 | -1.626 | -0.994 | -1.999 | -2.586 | -2.775 | -2.62 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 26,99M | 6,81M | 45,15M | 54,77M | 61M | 64,51M | 79,12M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 79,12M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 6,31M |
Ratio cours/bénéfice | -0,03 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,11 |
Ratio prix/valeur comptable | 0,01 |
Rendement de dividende | - |
Actions en circulation | 90,16M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales